Senate Finance Committee seeks to advance bipartisan PBM reforms alongside other health billsnews2023-11-02T19:47:09+00:00November 2nd, 2023|Endpoints News|
Otsuka partners with former Olympic swimmer on kidney disease campaignnews2023-11-02T19:13:31+00:00November 2nd, 2023|Endpoints News|
US argues that AstraZeneca’s IRA suit ‘fares no better than the others’news2023-11-02T19:11:16+00:00November 2nd, 2023|Endpoints News|
House Republicans threaten FDA with subpoena over alleged inadequate lab safety oversightnews2023-11-02T18:06:54+00:00November 2nd, 2023|Endpoints News|
FDA partially halts Nurix Therapeutics’ cancer trial as it improves manufacturing processnews2023-11-02T18:01:39+00:00November 2nd, 2023|Endpoints News|
Daiichi Sankyo to boost ADC manufacturing; Eli Lilly looks to outer space; new FDA initiative for manufacturing technews2023-11-02T16:45:37+00:00November 2nd, 2023|Endpoints News|
Radiopharma CDMOs navigate supply chain, raw material challenges as demand goes nuclearnews2023-11-02T16:19:53+00:00November 2nd, 2023|Endpoints News|
Moderna cuts back on manufacturing; Lilly eyes Mounjaro supply boost; GSK’s shingles vaccine ‘unconstrained’news2023-11-02T15:52:35+00:00November 2nd, 2023|Endpoints News|
Intellia suggests ATTR amyloidosis gene editing treatment has over a year of durability as it gears up for PhIIInews2023-11-02T15:18:11+00:00November 2nd, 2023|Endpoints News|
OrbiMed and Third Rock’s Terremoto Biosciences raises $175M for small molecule R&Dnews2023-11-02T14:59:35+00:00November 2nd, 2023|Endpoints News|
